SCHEMBL8552562

SCHEMBL8552562

C=CCOC(=O)c1ccc(CSC2CC(CC(=O)C(=O)OC)N2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.36
EPHX1 P07099 1/20 0.34
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CYP3A4 P08684 1/20 0.32
ALDH1A1 P00352 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
KDM4E B2RXH2 2/20 0.32
TP53 P04637 2/20 0.32
NPC1 O15118 2/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
RAB9A P51151 1/20 0.32
HSP90AA1 P07900 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
MMP13 P45452 1/20 0.32
ADRB2 P07550 1/20 0.31
ADRB1 P08588 1/20 0.31
ADRB3 P13945 1/20 0.31
MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8555621 0.90 SNCA (0.39) SNCACA1CA2CYP3A4ALDH1A1
SCHEMBL27511864 0.82 SNCA (0.41) SNCAEPHX1CA1CA2CYP3A4
SCHEMBL8300761 0.75 SNCA (0.42) SNCACA1CA2CYP3A4ALDH1A1
SCHEMBL27511532 0.71 SMN1; SMN2 (0.44) CA1CA2CYP3A4ALDH1A1SMN1; SMN2
SCHEMBL8305094 0.68 SNCA (0.43) SNCAEPHX1CYP3A4ALDH1A1KDM4E
SCHEMBL2705494 0.68 SNCA (0.58) SNCACA1CA2CYP3A4ALDH1A1
SCHEMBL8720293 0.68 SNCA (0.36) SNCAEPHX1CYP3A4ALDH1A1SMN1; SMN2
SCHEMBL8652713 0.68 EPHX1 (0.36) SNCAEPHX1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL8301034 0.68 SNCA (0.49) SNCACA1CA2CYP3A4ALDH1A1
SCHEMBL27484039 0.68 SNCA (0.51) SNCACYP3A4ALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0840725-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-05-13 EP disclosed
WO-1997002242-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-01-23 WO disclosed